Cite
HARVARD Citation
Mueller, R. et al. (2016). Change from subcutaneous to intravenous abatacept and back in patients with rheumatoid arthritis as simulation of a vacation: a prospective phase IV, open-label trial (A-BREAK). Arthritis research & therapy. 18 (1), pp. 1-6. [Online].